AAP News Vol. 30 No. 11 November 2009, p. 10
© 2009 American Academy of Pediatrics
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Related articles in AAP News
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Related Collections
Right arrow FDA Update
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

 Previous Article  |  Next Article 


FDA UPDATE

FDA public health alert: potential dosing errors with Tamiflu for Oral Suspension

Food and Drug Administration’s Office of Pediatric Therapeutics and Center for Drug Evaluation and Research


Figure 1

Confusion in dosing Tamiflu for Oral Suspension has resulted in dosing errors. These errors occurred because the dosing dispenser packaged with the product has markings only in milligrams (mg), while the dosing instructions provided to the patient were written in milliliters (mL) or teaspoons (tsp).

Health care providers should write doses in mg if the dosing dispenser with the drug is in mg. Pharmacists should ensure that the units of measure on the prescription instructions match the dosing device provided with the drug.

Following are specific considerations for Tamiflu for Oral Suspension dosing for children older than 1 year of age:

  • Dosing should be prescribed in mg (see tables below). Caregivers should use the dosing dispenser packaged with the medication, unless otherwise directed by a health care provider.
  • If the dosing dispenser packaged with Tamiflu oral suspension is lost or damaged, or if the prescriber wishes to use volume-based dosing, appropriate dosages in mL also are provided in the table. In these cases, the prescriber and pharmacist should ensure that a dosing dispenser (e.g., an oral syringe calibrated in mL) is given to the patient or caregiver with instructions for use. The dosing dispenser packaged with the product should be removed and discarded.
  • Prescribers should avoid prescribing Tamiflu oral suspension in "tsp." If a prescription is written in "tsp," the pharmacist should convert the volume to mL and ensure that an appropriate measuring device (e.g., an oral syringe calibrated in mL) is provided. The dosing dispenser packaged with the product should be removed and discarded.


Figure 2


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related articles in AAP News:

Adult Tamiflu capsules can be compounded for pediatric patients
John S. Bradley, Henry H. Bernstein, and Joseph A. Bocchini, Jr.
AAP News 2009 30: 1. [Full Text]  




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Related articles in AAP News
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Related Collections
Right arrow FDA Update
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?